Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
23847studies shown
Showing 18,505-18,516 of 23,847
Drug study icon
TerminatedNCT05804708

Phase 2 study of GH001 in Postpartum Depression

This study was terminated in the United Kingdom and in the Netherlands. It focuses on depression.

Multiple locations, including Amsterdam
DepressionDrugA study involving a medication or substance.From 18 Years to 45 Years
Countries
United Kingdom, Netherlands
Sponsor
GH Research Ireland Limited
Condition
Depression
Drug study icon
CompletedNCT05066672

NV-5138 for treatment-resistant depression

This study is completed in the United States. It is testing NV-5138 for treatment-resistant depression.

In Bellevue
DepressionDrugFrom 18 Years to 70 Years
Countries
United States
Sponsor
Navitor Pharmaceuticals, Inc.
Condition
Depression
Drug study icon
CompletedNCT00100165

Phase 2 study of a Nicotinic Agonist in Schizophrenia

This study is completed in the United States. It is testing Phase 2 Trial of a Nicotinic Agonist for schizophrenia.

In Denver
SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Colorado, Denver
Condition
Schizophrenia
Other study type icon
TerminatedEUCTR 2020-004752-16

EFFECTS OF RO6889450 for schizophrenia

This study was terminated in Spain, in Poland, in Bulgaria, .... It is testing EFFECTS OF RO6889450 for schizophrenia.

In Spain
SchizophreniaOther
Countries
Spain, Poland, Bulgaria, ...
Sponsor
F. Hoffmann-La Roche Ltd
Condition
Schizophrenia
Drug study icon
CompletedNCT00626236

Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems

This study exists to better understand the safety of the medication Safety and how manageable it feels in practice. Researchers are trying to understand whether the medication Safety can give earlier or clearer feedback during care.

Multiple locations, including Bradenton
ADHDDrugFrom 6 Years to 12 Years
Countries
United States
Sponsor
Supernus Pharmaceuticals, Inc.
Condition
ADHD
Drug study icon
CompletedNCT05712187

Phase 2b Study of ALTO-100 in MDD

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Birmingham
DepressionDrugFrom 18 Years to 64 Years
Countries
United States
Sponsor
Alto Neuroscience
Condition
Depression
Drug study icon
CompletedNCT00422123

Phase 3 /Seroquel SR Acute Mania Monotherapy - US

This study is completed in the United States. It focuses on Bipolarity.

Multiple locations, including Phoenix
Bipolarity, Schizophrenia, ...DrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Bipolarity, Schizophrenia, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.